Myositis associated with carbon monoxide poisoning.


Journal

Undersea & hyperbaric medicine : journal of the Undersea and Hyperbaric Medical Society, Inc
ISSN: 1066-2936
Titre abrégé: Undersea Hyperb Med
Pays: United States
ID NLM: 9312954

Informations de publication

Date de publication:
Historique:
entrez: 3 6 2019
pubmed: 4 6 2019
medline: 8 11 2019
Statut: ppublish

Résumé

Carbon monoxide (CO) poisoning causes hypoxia and inflammation, which could adversely affect muscle. We could find no published information about CO poisoning causing myositis. A 53-year-old previously healthy female semi truck driver had CO poisoning from a faulty diesel engine exhaust intermittently over three months, culminating in an episode of acute CO poisoning, with syncope after exiting the truck at the end of the three-month period. Neuropsychological symptoms immediately after the acute poisoning event were followed by the development of fatigue, weakness and myalgias within two months and a diagnosis of "polymyositis" within four months. C-reactive protein and creatine kinase were elevated. Electromyogram showed pure myopathy without sensory abnormalities. Occult malignancy was ruled out. Thigh muscle biopsy revealed severe inflammatory myopathy and myonecrosis. Muscle specialist pathologists interpreted the biopsy as toxic or viral inflammatory myopathy, not polymyositis, with CO poisoning as the likely etiology. She received steroids and mycophenolate. Nineteen months later, a repeat biopsy was negative for inflammation or myopathic process. Alternative diagnoses were ruled out by clinical investigation and her course over the next five years. This patient's presentation and clinical course support a diagnosis of myositis from CO poisoning, although it is possible that the myositis was either idiopathic or post-viral (without evidence of a causative virus).

Identifiants

pubmed: 31154686

Substances chimiques

Carboxyhemoglobin 9061-29-4

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

63-67

Informations de copyright

Copyright © Undersea and Hyperbaric Medical Society.

Déclaration de conflit d'intérêts

The authors of this paper declare no conflicts of interest exist with this submission.

Auteurs

Lindell K Weaver (LK)

Division of Hyperbaric Medicine Intermountain Medical Center, Murray, Utah U.S>.
Intermountain LDS Hospital, Salt Lake City, Utah U.S.
Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah U.S.

L Christine Oliver (LC)

Dalla Lana School of Public Health, Division of Occupational and Environmental Health, University of Toronto, Toronto, Ontario Canada.

Kayla Deru (K)

Division of Hyperbaric Medicine Intermountain Medical Center, Murray, Utah U.S>.

Anat O Stemmer-Rachamimov (AO)

Pathology, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts U.S.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH